Clozapine-Induced Myocarditis : Is Mandatory Monitoring Warranted for Its Early Recognition?
Joint Authors
Munshi, Tariq
Mazhar, Mir
Hassan, Tariq
Volochniouk, D.
Source
Issue
Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2014-01-23
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Clozapine is an atypical antipsychotic used for treatment resistant schizophrenia.
Its potential to induce agranulocytosis is well known but it can also cause myocarditis.
Clozapine is the only antipsychotic known to induce this side effect, typically early in the treatment, and literature is scarce on this condition.
We are presenting a case report of a 21-year-old schizophrenic male who developed myocarditis within 3 weeks of starting on clozapine for his treatment resistant psychosis.
We then aim to review some of the available literature and raise awareness among physicians as this condition can potentially be fatal if not detected early.
American Psychological Association (APA)
Munshi, Tariq& Volochniouk, D.& Hassan, Tariq& Mazhar, Mir. 2014. Clozapine-Induced Myocarditis : Is Mandatory Monitoring Warranted for Its Early Recognition?. Case Reports in Psychiatry،Vol. 2014, no. 2014, pp.1-4.
https://search.emarefa.net/detail/BIM-477572
Modern Language Association (MLA)
Munshi, Tariq…[et al.]. Clozapine-Induced Myocarditis : Is Mandatory Monitoring Warranted for Its Early Recognition?. Case Reports in Psychiatry No. 2014 (2014), pp.1-4.
https://search.emarefa.net/detail/BIM-477572
American Medical Association (AMA)
Munshi, Tariq& Volochniouk, D.& Hassan, Tariq& Mazhar, Mir. Clozapine-Induced Myocarditis : Is Mandatory Monitoring Warranted for Its Early Recognition?. Case Reports in Psychiatry. 2014. Vol. 2014, no. 2014, pp.1-4.
https://search.emarefa.net/detail/BIM-477572
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-477572